United States

Showing 221-230 of 328 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Market Analysis of Devices Utilized By Patients With T1D & Eligibility For Future T1D Cell and Gene Therapies	Milliman	Rebecca Smith	Cures	01-January-2025 to 31-October-2025	$380,000.00
Market Analysis of Insulin Products Utilized by Patients With T1D & Pervasiveness of Insulin Caps	Milliman	Rebecca Smith	Transportfolio	01-January-2025 to 01-October-2025	$545,000.00
Multicolor cellular immunoimaging of response to transplanted islet cells	Michigan State University	Bryan Smith	Cures	01-June-2023 to 31-May-2026	$750,000.00
Autoimmune stem-like T cells in type 1 diabetes	Memorial Sloan-Kettering Cancer Center	Andrea Schietinger	Cures	01-September-2023 to 31-August-2026	$750,000.00
Optimizing islet cell graft performance with targeted alpha and beta cell composition and distribution	Mayo Clinic	Quinn Peterson	Cures	01-April-2025 to 31-March-2027	$699,138.64
Assessment of Beta Cell Small Extracellular Vesicles in the Pathogenesis of Type 1 Diabetes	Mayo Clinic	Naureen Javeed	Cures	01-September-2022 to 31-August-2025	$400,000.00
Colonic Delivery of Butyrate to Improve Insulin Sensitivity and Lower Triglycerides in Type 1 Diabetes Patients	Mayo Clinic	Adrian Vella	Improving Lives	01-October-2019 to 31-March-2025	$437,405.39
A Nanosensor Embedded Device for Rapid Insulin Measurement	Massachusetts Institute of Technology	Michael Strano	Improving Lives	01-April-2024 to 31-March-2027	$600,000.00
Development of a safe and effective islet-targeted nanoplasmid based CXCL12 gene delivery system using cationic nanobubble-mediated sonotransfection to restore and immune protect the residual beta cell mass in T1D	Massachusetts General Hospital	Mark Poznansky	Cures	01-April-2023 to 31-March-2026	$777,168.00
Understanding common tissue tolerance mechanisms in autoimmunity	Massachusetts General Hospital	Gary Reynolds	Cures	01-September-2025 to 31-August-2026	$150,000.00